Amyloidosis, hereditary, transthyretin-related

Clinical trials for Amyloidosis, hereditary, transthyretin-related explained in plain language.

Never miss a new study

Get alerted when new Amyloidosis, hereditary, transthyretin-related trials appear

Sign up with your email to follow new studies for Amyloidosis, hereditary, transthyretin-related, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Can a daily pill keep a rare heart disease in check for the long haul?

Disease control Not yet recruiting

This study tests the long-term safety and tolerability of acoramidis, an oral medication that stabilizes the transthyretin protein, in people newly diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM), a condition that can lead to heart failure. Participants who complete…

Matched conditions: AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED

Phase 3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC

Amyloidosis, hereditary, transthyretin-related

Get alerted when new Amyloidosis, hereditary, transthyretin-related trials appear

Can a daily pill keep a rare heart disease in check for the long haul?